Cooley | China Business Law Journal


English English

Home Tags Posts tagged with "Cooley"

Tag: Cooley

Driverless firms Pony.ai, WeRide raise HKD9bn in HKEX IPOs

About 13 firms advised Guangzhou-based Pony.ai and WeRide on HKEX IPOs, raising HKD6.7b and HKD2.39b

Firms guide Seres on debut, HK’s largest carmaker IPO in 2025

Seres Group raised USD1.83bn in its HKEX debut, Hong Kong’s largest carmaker IPO and third-biggest listing of 2025, advised by Davis Polk, KWM, Cooley, Haiwen and Han Kun

Out-licensing is in

China's out-licensing boom: legal experts share tips for seamless pharma deals

Cooley shores up emerging companies, VC practice in Singapore

Cooley hires David He in Singapore to expand its venture capital practice

Firms act on Hengrui-GSK USD12.5bn drug development deal

Jiangsu Hengrui and GSK reached a USD12.5bn deal, with Cooley, Davis Polk and Han Kun advising

India rising, borders fading

As India expands its global trade ties and modernises its legal framework, international law firms are racing to keep pace

China Business Law Awards 2025

Which Chinese and international law firms have earned client trust through exceptional expertise?      

Firms lead on Cerebrus minority investment in Aquatech

CAM, Cooley, S&R Associates, and Saul Ewing advised on Cerberus Capital’s minority investment in Aquatech International for an undisclosed amount

Shashwat Tewary moves to Cooley as partner in Singapore

Shashwat Tewary has joined Cooley’s Singapore office as a capital markets partner, bringing 16 years of regional experience

AZB, CAM and Cooley act on Reliance’s RISE esports JV

AZB, CAM, and Cooley advised on the RISE esports joint venture between Reliance’s RISE Worldwide and Denmark-based BLAST Esports

Cooley adds partner in Singapore amid Indian IPO push

Cooley has hired Shashwat Tewary from Sidley Austin as a partner in Singapore, boosting their Indian and Southeast Asian capital markets expertise

The International A-list 2025

We reveal the most-recommended foreign lawyers for India-related matters

Skadden Beijing to welcome new leadership, says source

After Sun Kai and Xu Yilin left Skadden's Beijing office, a source says partners will relocate from Hong Kong and Shanghai

Data privacy compliance in Singapore

By Ferish Patel and Zhijing Yu, Cooley

Key legal considerations for Indian companies doing business in the city-state

Cooley grows capital markets with new partner in Beijing

Cooley has bolstered the talent at its Beijing office with the addition of capital markets partner Xu Yilin

ACC Singapore hosts sparkling year-end party

ACC Singapore hosted a "Sparkle and Cheer" year-end party on 5 December at PS Cafe

Proceed with caution

China's capital market faces tighter regulation, fewer new listings, and renewed interest in key international markets

China Business Law Awards 2024

China Business Law Journal reveals its top performing law firms of 2023

Rolling with the punches

The foreign firms that have overcome adversity and emerged as go-to choices for India legal matters

ACC Singapore’s first family day a hit

The Association of Corporate Counsel (ACC) Singapore held its first family day on 28 April at AT Feast in Dempsey

Investors ride wave of cross-border biomedical acquisitions

Amid the cool capital markets climate, the recent surge in billion-dollar M&A deals involving overseas biomedical companies

Legal luminaries celebrate at SCCA 21st annual black-tie event

Scores of legal luminaries helped the SCCA celebrate its 21st anniversary at the annual black-tie event

Six firms assist on AstraZeneca’s USD1.2bn Gracell purchase

Six firms act for parties involved with Anglo-Swedish pharmaceutical giant AstraZeneca’s acquisition of Chinese peer Gracell Biotechnologies for USD1.2 billion

Cooley, Davis Polk assist Chinese biopharma’s private placement

Cooley advises Gracell Biotechnologies, a Nasdaq-listed Chinese biopharmaceutical company, on its private placement financing of up to USD150 million

Cooley counsels Cholesgen on co-operation deal with AstraZeneca

Cooley assisted Cholesgen on its three-year co-operation contract with AstraZeneca, the British pharmaceutical giant, led by partner Christina Zhang

Five law firms advise on largest chapter 18A listing in Hong Kong

Five law firms advised on Chinese biotechnology company Laekna’s HKD791 million chapter 18A offering, which is the largest such IPO to date this year

China Business Law Awards 2023

China Business Law Journal reveals its top performing law firms of 2022

Cooley revamps leadership, refocuses practices

Cooley has revamped its Asian leadership, appointing its first partners in charge of the Hong Kong and Beijing offices, and resolving the succession of Christina Zhang, head of the Shanghai branch for more than a decade

Cooley restructures Asian leaderships, focuses on life sciences

Cooley has revamped its Asian leadership appointing its first partners in charge of the Hong Kong and Beijing offices, and resolved the succession of Christina Zhang, head of the Shanghai branch for more than a decade

Deals of the year 2022

India Business Law Journal reveals the standout deals and disputes of 2022 and the law firms that showed their worth in successfully concluding them

Structure Therapeutics raises USD180m in ADS offering

Biopharmaceutical company Structure Therapeutics raised USD134 million in a Nasdaq listing, offering 8.95 million American depositary shares (ADS) priced at USD15 each

Deals of the year 2022

China Business Law Journal announces the most exciting China-related legal transactions and disputes of 2022

Allen & Overy adds fund and asset management partner in Shanghai

Allen & Overy has strengthened its fund and asset management practice in the Asia-Pacific region with the hire of partner Daisy Qi to the Shanghai office

Former Morrison & Foerster partner joins Cooley’s Shanghai office

Cooley’s Shanghai office welcomed partner Li Ruomu to bolster the firm’s capabilities in mergers and acquisitions, private equity and venture capital transactions

China’s YishengBio eyes US capital markets via SPAC route

Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023

Bouncing back

Revealed: The top international law firms for India matters

HKEX gong chimes as GoGoX goes public

China’s third largest online logistics platform has debuted on the Hong Kong bourse – a move that summoned the strike of the gong back to the trading floor

China Business Law Awards 2022

China Business Law Journal reveals the law firms that have excelled in the past year

Deals of the Year

India Business Law Journal reveals the standout deals and disputes of 2021 and the law firms that worked hard to successfully conclude them

LATEST ON LAW.ASIA

[TEST] EXTEND CACHE DEV

Korea Law Firm Awards

[TEST] Extend Cache

Laws and regulations on private equity funds in Japan

By Yuki Sato, Chiho Saito and Taiki Hashimoto, So & Sato Law Offices

Navigating legality and validity of non-competes

By Zhu Tao and Guo Zhiyan, ETR Law Firm

MOST READ ON LAW.ASIA

Correspondents

Delhi High Court anti-arbitration injunction Singapore

India to be an outlier in dispute resolution

By Sneha Jaisingh and Rasika Alur, Bharucha & Partners
Strategic investor definition for REITs and InvITsvideo

Reforms widen REITs and InvITs investor base

By Parag Bhide, Bharucha & Partners
Reasonable Criteria For Tax Deductibility In Philippines

Reasonable criteria for tax deductibility in Philippines

By Jacqueline Ann A Tan, ACCRALAW
Foreign direct investment in India’s hospital sector

Hospitals in India a healthy investment opportunity

By Anand Jayachandran and Aditya Prasad, Cyril Amarchand Mangaldas

Follow us on LinkedIn

Follow now